Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

57,425 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
The association of body mass index with tumor aggression among men undergoing radical prostatectomy.
Gregg JR, Magill R, Fang AM, Chapin BF, Davis JW, Adibi M, Chéry L, Papadopoulos J, Pettaway C, Pisters L, Ward JF, Hahn AW, Daniel CR, Bhaskaran J, Zhu K, Guerrero M, Zhang M, Troncoso P. Gregg JR, et al. Among authors: zhang m. Urol Oncol. 2024 Apr;42(4):116.e1-116.e7. doi: 10.1016/j.urolonc.2023.12.013. Epub 2024 Jan 22. Urol Oncol. 2024. PMID: 38262868
Carcinoma of the urethra.
Zhang M, Adeniran AJ, Vikram R, Tamboli P, Pettaway C, Bondaruk J, Liu J, Baggerly K, Czerniak B. Zhang M, et al. Hum Pathol. 2018 Feb;72:35-44. doi: 10.1016/j.humpath.2017.08.006. Epub 2017 Aug 18. Hum Pathol. 2018. PMID: 28827100 Free PMC article.
Managing seminomatous and nonseminomatous germ cell tumors.
Chahoud J, Zhang M, Shah A, Lin SH, Pisters LL, Tu SM. Chahoud J, et al. Among authors: zhang m. Curr Opin Oncol. 2018 May;30(3):181-188. doi: 10.1097/CCO.0000000000000446. Curr Opin Oncol. 2018. PMID: 29538040 Review.
Detection and Treatment of Primary Prostatic Melanoma.
Li R, Zhang M, Duplisea JJ, Troncoso P, Ward JF. Li R, et al. Among authors: zhang m. Urology. 2019 Jan;123:16-19. doi: 10.1016/j.urology.2018.08.035. Epub 2018 Sep 5. Urology. 2019. PMID: 30195014 Review.
A Phase II Study of Cabozantinib and Androgen Ablation in Patients with Hormone-Naïve Metastatic Prostate Cancer.
Corn PG, Zhang M, Nogueras-Gonzalez GM, Xiao L, Zurita AJ, Subudhi SK, Tu SM, Aparicio AM, Coarfa C, Rajapakshe K, Huang S, Navone NM, Lin SH, Wang G, Ramachandran S, Titus MA, Panaretakis T, Gallick GE, Efstathiou E, Troncoso P, Logothetis C. Corn PG, et al. Among authors: zhang m. Clin Cancer Res. 2020 Mar 1;26(5):990-999. doi: 10.1158/1078-0432.CCR-19-2389. Epub 2020 Jan 15. Clin Cancer Res. 2020. PMID: 31941830 Clinical Trial.
57,425 results
You have reached the last available page of results. Please see the User Guide for more information.